nach oben

Der Nervenarzt

Erschienen in:

01.01.2008 | Übersichten

Nikotin und Gehirnentwicklung

verfasst von: Dr. C. Wessels, G. Winterer

Erschienen in: Der Nervenarzt | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Zusammenfassung

Tierexperimentelle und klinische Studien haben ergeben, dass eine Nikotinexposition während der Gehirnentwicklung – beginnend pränatal bis zur Adoleszenz – neben morphologischen Veränderungen zu einer persistierenden Beeinflussung neuronaler Transmissionssysteme führen kann.

Nikotinabhängigkeit sowie das Aufmerksamkeitsdefizit-Hyperaktivitäts-Syndrom sind mit einem Nikotinkonsum der Mütter der Betroffenen während der Schwangerschaft assoziiert. Auch finden sich erste Hinweise darauf, dass Nikotinmissbrauch in der Jugend die Funktion des zerebralen Aufmerksamkeitsnetzwerkes und das Gedächtnis nachhaltig beeinträchtigen kann. Unklar ist hingegen bislang noch, welche Auswirkungen eine Nikotinexposition auf die Entstehung von psychiatrischen Erkrankungen hat.

Die somatischen Konsequenzen des Zigarettenrauchens und die resultierenden gesundheitsökonomischen Probleme sind bekannt, die Auswirkungen einer während der Gehirnentwicklung stattfindenden Nikotinexposition werden derzeit noch unterschätzt. Es sollte mehr Aufklärung der Bevölkerung erfolgen, um Nikotinkonsum bereits während der Schwangerschaft sowie bei Kindern und Jugendlichen zu vermeiden.

Abreu-Villaca Y, Seidler FJ, Slotkin TA (2004) Does prenatal nicotine exposure sensitize the brain to nicotine-induced neurotoxicity in adolescence? Neuropsychopharmacology 29: 1440–1450PubMedCrossRef

Abreu-Villaca Y, Seidler FJ, Tate CA et al. (2004) Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. Neuropsychopharmacology 29: 879–890PubMedCrossRef

Bardy AH, Seppala T, Lillsunde P et al. (1993) Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol 100: 721–726PubMed

Buka SL, Shenassa ED, Niaura R (2003) Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry 160: 1978–1984PubMedCrossRef

Dahlstrom A, Ebersjo C, Lundell B (2004) Nicotine exposure in breastfed infants. Acta Paediatr 93: 810–816PubMedCrossRef

Ebert D, Berger M, Hesslinger B (2002) ADHD as a risk factor for delinquency and personality disorders? Recognizing the patient at risk. MMW Fortschr Med 144: 31–33PubMed

Ernst M, Moolchan ET, Robinson ML (2001) Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40: 630–641PubMedCrossRef

Ertan AK, He JP, Hendrik HJ et al. (2004) Reverse flow in fetal vessels and perinatal events. Z Geburtshilfe Neonatol 208: 141–149PubMedCrossRef

Eskenazi B, Castorina R (1999) Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect 107: 991–1000PubMedCrossRef

10.

Eskenazi B, Trupin LS (1995) Passive and active maternal smoking during pregnancy, as measured by serum cotinine, and postnatal smoke exposure. II. Effects on neurodevelopment at age 5 years. Am J Epidemiol 142: S19–S29PubMedCrossRef

11.

Faraone SV, Biederman J (1998) Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44: 951–958PubMedCrossRef

12.

Gainetdinov RR, Wetsel WC, Jones SR et al. (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283: 397–401PubMedCrossRef

13.

Ganapathy VV, Prasad PD, Ganapathy ME, Leibach FH (1999) Drugs of abuse and placental transport. Adv Drug Deliv Rev 38: 99–110PubMedCrossRef

14.

Garcia-Algar O, Puig C, Vall O et al. (2004) Effects of maternal smoking during pregnancy on newborn neurobehavior: neonatal nicotine withdrawal syndrome. Pediatrics 113: 623–624PubMedCrossRef

15.

Gardner TW, Dishion TJ, Posner MI (2006) Attention and adolescent tobacco use: A potential self-regulatory dynamic underlying nicotine addiction. Addict Behav 31: 531–536PubMedCrossRef

16.

Gaworski CL, Carmines EL, Faqi AS, Rajendran N (2004) In utero and lactation exposure of rats to 1R4F reference cigarette mainstream smoke: effect on prenatal and postnatal development. Toxicol Sci 79: 157–169PubMedCrossRef

17.

Jacobsen LK, D’Souza DC, Mencl WE et al. (2004) Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry 55: 850–858PubMedCrossRef

18.

Jacobsen LK, Krystal JH, Mencl WE et al. (2005) Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 57: 56–66PubMedCrossRef

19.

Jacobsen LK, Pugh KR, Constable RT et al. (2007) Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biol Psychiatry 61: 31–40PubMedCrossRef

20.

Jacobsen LK, Slotkin TA, Westerveld M et al. (2006) Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking. Neuropsychopharmacology 31: 1550–1561PubMedCrossRef

21.

Lambers DS, Clark KE (1996) The maternal and fetal physiologic effects of nicotine. Semin Perinatol 20: 115–126PubMedCrossRef

22.

Lambert NM, Hartsough CS (1998) Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 31: 533–544PubMedCrossRef

23.

Law KL, Stroud LR, LaGasse LL et al. (2003) Smoking during pregnancy and newborn neurobehavior. Pediatrics 111: 1318–1323PubMedCrossRef

24.

Linnet KM, Dalsgaard S, Obel C et al. (2003) Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 160: 1028–1040PubMedCrossRef

25.

Linnet KM, Wisborg K, Obel C et al. (2005) Smoking during pregnancy and the risk for hyperkinetic disorder in offspring. Pediatrics 116: 462–467PubMedCrossRef

26.

Machaalani R, Waters KA, Tinworth KD (2005) Effects of postnatal nicotine exposure on apoptotic markers in the developing piglet brain. Neuroscience 132: 325–333PubMedCrossRef

27.

McFarland BJ, Seidler FJ, Slotkin TA (1991) Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration. Brain Res Dev Brain Res 58: 223–229PubMedCrossRef

28.

Meyberg R, Boos R, Babajan A et al. (2000) Intrauterine growth retardation--perinatal mortality and postnatal morbidity in a perinatal center. Z Geburtshilfe Neonatol 204: 218–223PubMedCrossRef

29.

Milberger S, Biederman J, Faraone SV et al. (1996) Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry 153: 1138–1142PubMed

30.

Muneoka K, Ogawa T, Kamei K et al. (1997) Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res Dev Brain Res 102: 117–126PubMedCrossRef

31.

Musso F, Bettermann F, Vucurevic G et al. (2007) Smoking impacts on prefrontal attentional network function in young adult brains. Psychopharmacology 191: 159–169PubMedCrossRef

32.

Navarro HA, Seidler FJ, Schwartz RD et al. (1989) Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res Bull 23: 187–192PubMedCrossRef

33.

Nordberg A, Zhang XA, Fredriksson A, Eriksson P (1991) Neonatal nicotine exposure induces permanent changes in brain nicotinic receptors and behaviour in adult mice. Brain Res Dev Brain Res 63: 201–207PubMedCrossRef

34.

Obel C, Henriksen TB, Hedegaard M et al. (1998) Smoking during pregnancy and babbling abilities of the 8-month-old infant. Paediatr Perinat Epidemiol 12: 37–48PubMedCrossRef

35.

Oncken C, McKee S, Krishnan-Sarin S et al. (2004) Gender effects of reported in utero tobacco exposure on smoking initiation, progression and nicotine dependence in adult offspring. Nicotine Tob Res 6: 829–833PubMedCrossRef

36.

Oncken CA, Henry KM, Campbell WA et al. (2003) Effect of maternal smoking on fetal catecholamine concentrations at birth. Pediatr Res 53: 119–124PubMed

37.

Porath AJ, Fried PA (2005) Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol 27: 267–277PubMedCrossRef

38.

Robinson DM, Peebles KC, Kwok H et al. (2002) Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice. J Physiol 538: 957–973PubMedCrossRef

39.

Roy TS, Andrews JE, Seidler FJ, Slotkin TA (1998) Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther 287: 1136–1144PubMed

40.

Slawecki CJ, Thomas JD, Riley EP, Ehlers CL (2000) Neonatal nicotine exposure alters hippocampal EEG and event-related potentials (ERPs) in rats. Pharmacol Biochem Behav 65: 711–718PubMedCrossRef

41.

Slikker W Jr, Xu ZA, Levin ED, Slotkin TA (2005) Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction – developmental neurotoxicity of nicotine. Crit Rev Toxicol 35: 703–711PubMedCrossRef

42.

Slotkin TA (1998) Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 285: 931–945PubMed

43.

Slotkin TA (2002) Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol Teratol 24: 369–384PubMedCrossRef

44.

Slotkin TA (2004) Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 198: 132–151PubMedCrossRef

45.

Slotkin TA, McCook EC, Seidler FJ (1997) Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res 750: 180–188PubMedCrossRef

46.

Slotkin TA, Pinkerton KE, Garofolo MC et al. (2001) Perinatal exposure to environmental tobacco smoke induces adenylyl cyclase and alters receptor-mediated cell signaling in brain and heart of neonatal rats. Brain Res 898: 73–81PubMedCrossRef

47.

Slotkin TA, Pinkerton KE, Seidler FJ (2006) Perinatal environmental tobacco smoke exposure in rhesus monkeys: critical periods and regional selectivity for effects on brain cell development and lipid peroxidation. Environ Health Perspect 114: 34–39PubMedCrossRef

48.

Spivak B, Vered Y, Yoran-Hegesh R et al. (1999) Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. Acta Psychiatr Scand 99: 300–304PubMedCrossRef

49.

Sugiyama H, Hagino N, Moore G, Lee JW (1985) [3H]Nicotine binding sites in developing fetal brains in rats. Neurosci Res 2: 387–392PubMedCrossRef

50.

Thapar A, Fowler T, Rice F et al. (2003) Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry 160: 1985–1989PubMedCrossRef

51.

Thomas JD, Garrison ME, Slawecki CJ et al. (2000) Nicotine exposure during the neonatal brain growth spurt produces hyperactivity in preweanling rats. Neurotoxicol Teratol 22: 695–701PubMedCrossRef

52.

Tizabi Y, Manaye KF, Taylor RE (2005) Nicotine blocks ethanol-induced apoptosis in primary cultures of rat cerebral cortical and cerebellar granule cells. Neurotox Res 7: 319–322PubMedCrossRef

53.

Trauth JA, McCook EC, Seidler FJ, Slotkin TA (2000) Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. Brain Res 873: 18–25PubMedCrossRef

54.

Wang X, Zuckerman B, Pearson C et al. (2002) Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287: 195–202PubMedCrossRef

55.

Zhou M, Suszkiw JB (2004) Nicotine attenuates spatial learning deficits induced in the rat by perinatal lead exposure. Brain Res 999: 142–147PubMedCrossRef

Titel: Nikotin und Gehirnentwicklung
verfasst von: Dr. C. Wessels
G. Winterer
Publikationsdatum: 01.01.2008
Verlag: Springer-Verlag
Erschienen in: Der Nervenarzt / Ausgabe 1/2008
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI: https://doi.org/10.1007/s00115-007-2392-z

Neu in den Fachgebieten Neurologie und Psychiatrie

23.04.2024 | Demenz | Nachrichten

Springer Medizin

Nikotin und Gehirnentwicklung

Zusammenfassung

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

Pharmakotherapie bei Schizophrenie und komorbider Substanzstörung

Malignes neuroleptisches Syndrom durch Amisulprid

Behandlung der Demenz bei Parkinson-Syndromen

Therapie kognitiver Defizite durch AChE-Hemmer bei Patienten mit Schizophrenie

Mitteilungen DGPPN 1/08

Hochverbrauch von Zolpidem und Zopiclon

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein